Phase I Study of HRS-8797 Initiated by Chengdu Suncadia Medicine
Chengdu Suncadia Medicine Co., Ltd. has initiated Phase I clinical trial to evaluate HRS-8797.
Asset / Drug
Drug and asset intelligence for HRS-8797 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.